Rapid identification of Candida spp

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Vaccines for the elderly
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
The use of Raman spectroscopy in the epidemiology of methicillin-resistant Staphylococcus aureus of human- and animal-related clonal lineages  M.W.H.
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
O. Clerc, G. Greub  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Potential risk factors for infection with Candida spp
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
Diagnosing infections—current and anticipated technologies for point-of-care diagnostics and home-based testing  L. Bissonnette, M.G. Bergeron  Clinical.
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
Epidemiology of opportunistic infections in AIDS patients
F. Bittar, J.-M. Rolain  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008  C.-K. Tan, C.-C.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Previously unknown species of Aspergillus
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
The practice of travel medicine in Europe
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
Current experience in treating invasive zygomycosis with posaconazole
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida 
Antimicrobial drug development – the past, the present, and the future
Vaccines for the elderly
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
I. Bitar, A. Piazza  Clinical Microbiology and Infection 
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
O. Clerc, G. Greub  Clinical Microbiology and Infection 
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS  P. Espinal, H. Seifert, L. Dijkshoorn,
Presentation transcript:

Rapid identification of Candida spp Rapid identification of Candida spp. in peritonitis patients by Raman spectroscopy  M.S. Ibelings, K. Maquelin, H. Ph. Endtz, H.A. Bruining, G.J. Puppels  Clinical Microbiology and Infection  Volume 11, Issue 5, Pages 353-358 (May 2005) DOI: 10.1111/j.1469-0691.2005.01103.x Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Representative Raman spectra of ten Candida spp. used to establish the Candida database in this study. The shaded areas highlight some characteristic differences between the species (a.u. = arbitrary units). Clinical Microbiology and Infection 2005 11, 353-358DOI: (10.1111/j.1469-0691.2005.01103.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Schematic representation of the sequential species identification procedure, based on the Candida database LDA model 1–6. Spectra of trial specimens to be identified are predicted by using model 1, followed by the next projections. Clinical Microbiology and Infection 2005 11, 353-358DOI: (10.1111/j.1469-0691.2005.01103.x) Copyright © 2005 European Society of Clinical Infectious Diseases Terms and Conditions